Similar Papers

Paper Title
Journal
Date
Author
90 Ultra-Hypo (UHF) Compared to Moderate-Hypo (MHF) Fractionated Prostate IGRT with HDR Brachytherapy Boost: Long Term Toxicity, Acceptability and Efficiency of Delivery
André-Guy Martin ... Luc Beaulieu
Radiotherapy and Oncology | VOL. 139
André-Guy Martin, et. al.André-Guy Martin ... Luc Beaulieu
01 Oct 2019
Hypofractionated Whole-Breast-IMRT with HDR Brachytherapy Boost in Early-Stage Breast Cancer: Long Term Results of a Single Center Study
A Diaz-Gavela ... F Counago
International Journal of Radiation Oncology*Biology*Physics | VOL. 114
A Diaz-Gavela, et. al.A Diaz-Gavela ... F Counago
22 Oct 2022
Earlier Administration of Rituximab Allows Higher Rate of Long-Lasting Response in Adult Patients with Autoimmune Thrombocytopenia.
Francesco F Zaja ... Renato R Fanin
Blood | VOL. 106
Francesco F Zaja, et. al.Francesco F Zaja ... Renato R Fanin
16 Nov 2005
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
Tianyu Zhou ... Nuo Xu
Clinical and translational radiation oncology | VOL. 40
Tianyu Zhou, et. al.Tianyu Zhou ... Nuo Xu
08 Feb 2023
View more papers

More From: International Journal of Radiation Oncology*Biology*Physics

Paper Title
Journal
Date
Author
Defining the optimal radiation-induced lymphopenia metric to discern its survival impact in esophageal cancer.
Pim J.J Damen ... Peter S.N Van Rossum
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Pim J.J Damen, et. al.Pim J.J Damen ... Peter S.N Van Rossum
01 Jan 2025
Issue Highlights
-
International Journal of Radiation Oncology*Biology*Physics | VOL. -
--
01 Jan 2025
Combined molecular subclass and immune phenotype correlate to atezolizumab plus radiation therapy response in invasive bladder cancer: BPT-ART Phase II study
Yoshiyuki Nagumo ... Hiroyuki Nishiyama
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Yoshiyuki Nagumo, et. al.Yoshiyuki Nagumo ... Hiroyuki Nishiyama
01 Jan 2025
Pelvic regional control with 25Gy in 5 fractions in SBRT for high risk prostate cancer: Pooled prospective outcomes from the SHARP consortium
Vedang Murthy ... Amar U Kishan
International Journal of Radiation Oncology*Biology*Physics | VOL. -
Vedang Murthy, et. al.Vedang Murthy ... Amar U Kishan
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.